RTI Surgical Holdings Inc. (NASDAQ:RTIX) designs and manufactures biologic, metal and synthetic implants specializing in applications for the human spine. The company just announced it agreed to sell its "OEM" product segment to Montagu Private Equity LLP for $490 million. This is a major transaction considering RTIX was trading at a market capitalization of just $200 million before the deal. The stock initially surged by over 100% on the report. Putting the numbers together, we think the deal positively transforms the company in both its strategic direction and financial position, representing a bullish